全球周邊血單核細胞（PBMC）市場

預計到 2025 年，全球周邊血單核細胞 (PBMC) 市場規模為 3.222 億美元，到 2026 年將達到 3.539 億美元，到 2031 年將達到 5.772 億美元，2026 年至 2031 年的年複合成長率（CAGR）為 10.3%。

調查範圍

本報告概述了全球周邊血單核細胞（PBMC）市場，並分析了市場趨勢。報告包括以2025年為基準年的全球銷售額數據（千美元）、2026年的估計數據以及2026年至2031年的預測數據。

本報告按產品類型、應用和技術對市場進行細分。依產品類型分類，市場分為冷凍保存或冷凍周邊血單核細胞 (PBMC)、周邊血單核細胞分離和活力評估試劑盒、培養或活體 PBMC 以及其他產品。依應用分類，市場分為腫瘤學、免疫學、疫苗研發、毒理學、感染疾病等領域。依技術分類，市場分為密度梯度離心法、白血球分離法等技術。本研究涵蓋的地區包括北美（美國、加拿大、墨西哥）、歐洲（德國、英國、義大利、法國、西班牙及其他歐洲國家）、亞太地區（中國、日本、印度、韓國、澳洲及其他亞太國家）、南美洲以及中東和非洲 (MEA)，並專注於這些地區的主要國家。

本報告重點在於影響市場和供應商格局的關鍵促進因素、趨勢和挑戰，並對與市場相關的新興技術進行分析和探討。

本報告最後對競爭格局進行了分析，重點介紹了周邊血單核細胞研究領域的全球領導者。報告還包含專門的公司簡介章節，涵蓋每家公司的概況、關鍵財務資訊、產品系列和最新進展。

本報告內容

• 數據表 40 及補充表 54
• 本研究調查涵蓋全球周邊血單核細胞 (PBMC) 市場，包括研究應用、技術發展以及免疫細胞化學在生命科學和臨床研究中日益擴大的作用。
• 市場規模估算是根據 2025 年的數據，以及 2026 年至 2031 年的銷售預測和成長預測。
• 按產品類型、應用和分離技術進行市場細分分析。
• 分析影響產業成長和採用趨勢的關鍵市場促進因素、限制因素、機會和挑戰。
• 涵蓋北美、歐洲、亞太、南美以及中東和非洲的區域評估。包括對重點研究和醫療保健市場的國別分析。
• 競爭格局評估，包括公司排名、市場佔有率分析以及主要市場參與企業的策略舉措。
• 對參與周邊血單核細胞（PBMC）市場的成熟新興企業進行公司簡介。重點關注每家公司的產品線、商業策略和最新發展。
• 業界領導企業的公司簡介，包括 BioIVT、CGT Global、Charles River Laboratories、Discovery Life Sciences、Lonza 和 STEMCELL Technologies。

目錄

第1章執行摘要

第2章 市場概覽

• 概述
• 周邊血單核細胞的來源
• 周邊血單核細胞的分離方法
• 周邊血單核細胞的凍融
• 周邊血單核細胞的應用
• 宏觀經濟因素分析
• 醫療保健和生命科學領域的研發支出
• 以色列、美國和伊朗之間戰爭的影響
• 周邊血單核細胞市場的波特五力分析

第3章 市場動態

• 市場動態
• 市場促進因素
• 對免疫學和疫苗研究的需求日益成長
• 細胞和基因療法的開發不斷擴展
• 擴大周邊血單核細胞在生物標記和感染疾病的應用
• 市場限制因素
• 處理和儲存周邊血單核細胞成本高昂
• 與樣本變異性和活力相關的問題
• 市場機遇
• 精準醫療和生物銀行的擴展
• 新興市場
• 市場挑戰
• 冷鍊和物流的複雜性
• 倫理和監管問題

第4章 監管情勢

• 美國
• 歐洲
• 其他地區

第5章：新興科技與趨勢

• 新興技術
• PBMC自動分離系統
• 先進的冷凍保存技術與無DMSO技術
• 人工智慧
• 臨床試驗分析
• 臨床試驗分析：依研究類型
• 臨床試驗分析：按狀態
• 臨床試驗分析：按階段
• 專利分析
• 按年份統計的專利數量
• 由頂尖候選人
• 由主要所有者
• 按管轄權

第6章 市場區隔分析

• 細分市場
• 市場分析：依產品類型
• 冷凍儲存或冷凍處理的PBMC
• 周邊血單核細胞分離與活力測定試劑盒
• 培養的PBMC或活的PBMC
• 其他
• 市場分析：按技術分類
• 密度梯度離心
• 白血球分離法
• 其他技術
• 市場分析：按應用領域
• 腫瘤學
• 免疫學
• 感染疾病
• 疫苗研發
• 毒理學
• 其他用途
• 按地區分類
• 市場分析：按地區分類
• 北美洲
• 歐洲
• 亞太地區
• 南美洲
• 中東和非洲（MEA）

第7章 競爭情勢

• 競爭格局
• PBMC市場的主要公司
• 主要發展和策略

第8章附錄

• 調查方法
• 資訊來源
• 簡稱
• 公司簡介
• AKADEUM LIFE SCIENCES
• ATCC
• BIOIVT
• BIOLEGEND INC.
• CGT GLOBAL
• CHARLES RIVER LABORATORIES
• CYTIVA
• DISCOVERY LIFE SCIENCES
• IXCELLS BIOTECHNOLOGIES
• LONZA
• MERCK KGAA
• MILTENYI BIOTEC
• PRECISION MEDICINE GROUP LLC
• STEMCELL TECHNOLOGIES
• THERMO FISHER SCIENTIFIC INC.
• 新興創業公司/市場顛覆者

The global market for peripheral blood mononuclear cells (PBMCs) was valued at $322.2 million in 2025 and, is estimated to reach $353.9 million by 2026 and $577.2 million by 2031, at a compound annual growth rate (CAGR) of 10.3% from 2026 through 2031.

Report Scope

The report provides an overview of the global peripheral blood mononuclear cells (PBMCs) market and analyzes market trends. It includes global revenue ($ Thousand) using 2025 as the base year, estimated data for 2026, and projected data for 2026 through 2031.

The report segments the market by product type, application, and technology. By product type, the market is segmented into cryopreserved or frozen PBMCs, peripheral blood mononuclear cell isolation and viability kits, cultured or fresh PBMCs, and others. Based on application, the market is categorized into oncology, immunology, vaccine development, toxicology, infectious disease, and others. By technology, the market is segmented into density gradient centrifugation, leukapheresis, and others. Geographical regions covered in this study include North America (the U.S., Canada, and Mexico), Europe (Germany, the U.K., Italy, France, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia-Pacific), South America, and the Middle East and Africa (MEA) with a focus on the major countries in these regions.

The report focuses on the key drivers, trends, and challenges shaping the market and vendor landscape. It analyzes and discusses emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape and highlights the leading global peripheral blood mononuclear cell companies. It also includes a dedicated section of company profiles covering company overviews, key financials, product portfolios, and recent developments.

Report Includes

• 40 data tables and 54 additional tables
• Examination of the global peripheral blood mononuclear cells (PBMCs) market, covering research applications, technological developments, and the growing role of immune cell analysis in life sciences and clinical research
• Market estimates based on 2025 data, with revenue forecasts and growth projections for the period from 2026 through 2031
• Analysis of market segments by product type, application, and isolation technique,
• Discussion of key market drivers, restraints, opportunities, and challenges influencing industry growth and adoption patterns
• Regional evaluation of North America, Europe, Asia-Pacific, South America, and the Middle East & Africa, including country-level analysis of major research and healthcare markets
• Competitive landscape assessment featuring company rankings, market share analysis, and strategic initiatives undertaken by leading market participants
• Profiles of established companies and emerging players involved in the PBMC market, highlighting their product offerings, business strategies, and recent developments
• Company profiles of major players within the industry, including BioIVT, CGT Global, Charles River Laboratories, Discovery Life Sciences, Lonza, and STEMCELL Technologies

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Overview
• Current Market Scenario
• Segmental Analysis
• Regional Analysis
• Technological Advances
• Conclusion

Chapter 2 Market Overview

• Overview
• Source of PBMCs
• Method of PBMC Isolation
• Freezing and Thawing of PBMCs
• Applications for PBMCs
• Macroeconomic Factor Analysis
• Healthcare and Life Sciences R&D Expenditure
• Impact of the Israel-U.S. and Iran war
• Porter's Five Forces Analysis in the Peripheral Blood Mononuclear Cells Market
• Potential for New Entrants (Moderate)
• Bargaining Power of Suppliers (High)
• Bargaining Power of Buyers (Moderate)
• Threat of Substitutes (Moderate to High)
• Competition in the Industry (High)

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Rising Immunology and Vaccine Research Demand
• Growing Cell and Gene Therapy Development
• Increasing Use of PBMCs in Biomarkers and Infectious Diseases
• Market Restraints
• High PBMC Processing and Storage Costs
• Sample Variability and Viability Issues
• Market Opportunities
• Expansion of Precision Medicine and Biobanking
• Emerging Markets
• Market Challenges
• Cold-Chain and Logistics Complexity
• Ethical and Regulatory Concerns

Chapter 4 Regulatory Landscape

• U.S.
• Europe
• Other Regions

Chapter 5 Emerging Technologies and Developments

• Emerging Technologies
• Automated PBMC Isolation Systems
• Advanced Cryopreservation and DMSO-Free Technologies
• Artificial Intelligence
• Clinical Trials Analysis
• Key Takeaways
• Clinical Trials Analysis, by Type of Study
• Clinical Trials Analysis, by Status
• Clinical Trials Analysis, by Phase
• Patent Analysis
• Key Takeaways
• Patents, by Year
• By Top Applicant
• By Top Owner
• By Jurisdiction

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis by Product Type
• Key Takeaways
• Cryopreserved or Frozen PBMC
• Peripheral Blood Mononuclear Cell Isolation and Viability Kits
• Cultured or Fresh PBMC
• Others
• Market Analysis by Technology
• Key Takeaways
• Density Gradient Centrifugation
• Leukapheresis
• Other Technologies
• Market Analysis by Application
• Key Takeaways
• Oncology
• Immunology
• Infectious Disease
• Vaccine Development
• Toxicology
• Other Applications
• Geographic Breakdown
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa (MEA)

Chapter 7 Competitive Intelligence

• Key Takeaways
• Competitive Landscape
• Leading Companies of the PBMC Market
• Key Developments and Strategies

Chapter 8 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• AKADEUM LIFE SCIENCES
• ATCC
• BIOIVT
• BIOLEGEND INC.
• CGT GLOBAL
• CHARLES RIVER LABORATORIES
• CYTIVA
• DISCOVERY LIFE SCIENCES
• IXCELLS BIOTECHNOLOGIES
• LONZA
• MERCK KGAA
• MILTENYI BIOTEC
• PRECISION MEDICINE GROUP LLC
• STEMCELL TECHNOLOGIES
• THERMO FISHER SCIENTIFIC INC.
• Emerging Start-ups/ Market Disruptors

List of Tables

• Summary Table : Global Market for Peripheral Blood Mononuclear Cells (PBMCs), by Region, Through 2031
• Table 1 : Composition of Human PBMCs
• Table 2 : Porter's Five Forces Analysis: Overview
• Table 3 : PBMC-Related Cost, 2026
• Table 4 : Other Regions: PBMC Regulatory Landscape
• Table 5 : Clinical Trials in PBMCs, by Type of Study, June 2026
• Table 6 : Clinical Trials in PBMC, by Status, June 2026
• Table 7 : Clinical Trials in PBMCs, by Phase, June 2026
• Table 8 : Patents, by Top Applicant, 2023-2025
• Table 9 : Patents, by Top Owner, 2023-2025
• Table 10 : Patents, by Jurisdiction, 2023-2025
• Table 11 : Global Market for PBMCs, by Product Type, Through 2031
• Table 12 : Global Market for Cryopreserved or Frozen PBMCs, by Region, Through 2031
• Table 13 : Major Manufacturers of PBMC Isolation and Viability Kits
• Table 14 : Global Market for PBMC Isolation and Viability Kits, by Region, Through 2031
• Table 15 : Global Market for Cultured or Fresh PBMC, by Region, Through 2031
• Table 16 : Global Market for Other PBMC Products, by Region, Through 2031
• Table 17 : Global Market for PBMC, by Technology, Through 2031
• Table 18 : Global Market for Density Gradient Centrifugation of PBMCs, by Region,Through 2031
• Table 19 : Global Market for Leukapheresis of PBMCs, by Region, Through 2031
• Table 20 : Global Market for Other Technologies of PBMCs, by Region, Through 2031
• Table 21 : Global Market for PBMCs, by Application, Through 2031
• Table 22 : Global Market for Oncology Applications of PBMCs, by Region, Through 2031
• Table 23 : Global Market for Immunology Applications of PBMCs, by Region, Through 2031
• Table 24 : Global Market for Infectious Disease Applications of PBMCs, by Region,Through 2031
• Table 25 : Global Market for Vaccine Development Applications of PBMCs, by Region, Through 2031
• Table 26 : Global Market for Toxicology Applications of PBMCs, by Region, Through 2031
• Table 27 : Global Market for Other Applications of PBMCs, by Region, Through 2031
• Table 28 : Global Market for PBMCs, by Region, Through 2031
• Table 29 : North American Market for PBMCs, by Country, Through 2031
• Table 30 : North American Market for PBMCs, by Product Type, Through 2031
• Table 31 : North American Market for PBMCs, by Technology, Through 2031
• Table 32 : North American Market for PBMCs, by Application, Through 2031
• Table 33 : European Market for PBMCs, by Country, Through 2031
• Table 34 : European Market for PBMCs, by Product Type, Through 2031
• Table 35 : European Market for PBMCs, by Technology, Through 2031
• Table 36 : European Market for PBMCs, by Application, Through 2031
• Table 37 : Asia-Pacific Market for PBMCs, by Country, Through 2031
• Table 38 : Asia-Pacific Market for PBMCs, by Product Type, Through 2031
• Table 39 : Asia-Pacific Market for PBMCs, by Technology, Through 2031
• Table 40 : Asia-Pacific Market for PBMCs, by Application, Through 2031
• Table 41 : South American Market for PBMCs, by Product Type, Through 2031
• Table 42 : South American Market for PBMCs, by Technology, Through 2031
• Table 43 : South American Market for PBMCs, by Application, Through 2031
• Table 44 : MEA Market for PBMCs, by Product Type, Through 2031
• Table 45 : MEA Market for PBMCs, by Technology, Through 2031
• Table 46 : MEA Market for PBMCs, by Application, Through 2031
• Table 47 : Competitive Analysis of the Global PBMCs Market, 2025
• Table 48 : PBMC Market: Recent Strategic Developments, 2024-2026
• Table 49 : Report Information Sources
• Table 50 : Abbreviations Used in the PBMCs Market Report
• Table 51 : Akadeum Life Sciences: Company Snapshot
• Table 52 : Akadeum Life Sciences: Product Portfolio
• Table 53 : Akadeum Life Sciences: News/Key Developments, 2025-2026
• Table 54 : ATCC: Company Snapshot
• Table 55 : ATCC: Product Portfolio
• Table 56 : ATCC: News/Key Development, 2024
• Table 57 : BioIVT: Company Snapshot
• Table 58 : BioIVT: Product Portfolio
• Table 59 : BioIVT: News/Key Development, 2024
• Table 60 : BioLegend Inc.: Company Snapshot
• Table 61 : BioLegend Inc.: Product Portfolio
• Table 62 : CGT Global: Company Snapshot
• Table 63 : CGT Global: Product Portfolio
• Table 64 : Charles River Laboratories: Company Snapshot
• Table 65 : Charles River Laboratories: Financial Performance, FY 2024 and 2025
• Table 66 : Charles River Laboratories: Product Portfolio
• Table 67 : Cytiva: Company Snapshot
• Table 68 : Cytiva: Product Portfolio
• Table 69 : Discovery Life Sciences: Company Snapshot
• Table 70 : Discovery Life Sciences: Product Portfolio
• Table 71 : Discovery Life Sciences: News/Key Development, 2024
• Table 72 : iXCells Biotechnologies: Company Snapshot
• Table 73 : iXCells Biotechnologies: Product Portfolio
• Table 74 : iXCells Biotechnologies: News/Key Development, 2026
• Table 75 : Lonza: Company Snapshot
• Table 76 : Lonza: Financial Performance, FY 2024 and 2025
• Table 77 : Lonza: Product Portfolio
• Table 78 : Merck KGaA: Company Snapshot
• Table 79 : Merck KGaA: Financial Performance, FY 2024 and 2025
• Table 80 : Merck KGaA: Product Portfolio
• Table 81 : Miltenyi Biotec: Company Snapshot
• Table 82 : Miltenyi Biotec: Product Portfolio
• Table 83 : Miltenyi Biotec: News/Key Development, 2024
• Table 84 : Precision Medicine Group LLC: Company Snapshot
• Table 85 : Precision Medicine Group LLC: Product Portfolio
• Table 86 : Precision Medicine Group LLC: News/Key Development, 2026
• Table 87 : STEMCELL Technologies: Company Snapshot
• Table 88 : STEMCELL Technologies: Product Portfolio
• Table 89 : STEMCELL Technologies: News/Key Development, 2025
• Table 90 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 91 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2024 and 2025
• Table 92 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 93 : List of Few Emerging Start-ups/ Market Disruptors

List of Figures

• Summary Figure : Global Market Shares of Peripheral Blood Mononuclear Cells (PBMCs), by Region, 2025
• Figure 1 : Porter's Five Forces Analysis of the PBMC Market
• Figure 2 : Market Dynamics of PBMC
• Figure 3 : Emerging Trends/Technologies in the PBMC Market
• Figure 4 : Patents Granted, by Year, 2023-2025
• Figure 5 : Global Market Shares of PBMCs, by Product Type, 2025
• Figure 6 : Global Market Shares of PBMC, by Technology, 2025
• Figure 7 : Global Market Shares of PBMCs, by Application, 2025
• Figure 8 : Global Market Shares of PBMCs, by Region, 2025
• Figure 9 : North American Market Shares of PBMCs, by Country, 2025
• Figure 10 : European Market Shares of PBMCs, by Country, 2025
• Figure 11 : Asia-Pacific Market Shares of PBMCs, by Country, 2025
• Figure 12 : Charles River Laboratories: Revenue Shares, by Business Unit, FY 2025
• Figure 13 : Charles River Laboratories: Revenue Shares, by Country/Region, FY 2025
• Figure 14 : LONZA: Revenue Shares, by Business Unit, FY 2025
• Figure 15 : LONZA: Revenue Shares, by Country/Region, FY 2025
• Figure 16 : Merck KGaA: Revenue Shares, by Business Unit, FY 2025
• Figure 17 : Merck KGaA: Revenue Shares, by Country/Region, FY 2025
• Figure 18 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2025
• Figure 19 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2025